The evolution of Bordetella pertussis and Bordetella parapertussis from Bordetella bronchiseptica involved changes in host range and pathogenicity. Recent data suggest that the human-adapted Bordetella modified their interaction with host immune systems to effect these changes and that decreased stimulation of Toll-like receptor 4 (TLR4) by lipid A is central to this. We discuss Bordetella lipid A structure and genetics within the context of evolution and host immunity.
Cherry JDPertussis — the trials and tribulations of old and new pertussis vaccines . Vaccine1992; 10: 1033—1038.
2.
Cherry JDHistorical review of pertussis and the classical vaccine. J Infect Dis1996; 174: S259—S263.
3.
Heininger U., Stehr K., Schmittgrohe S. et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J1994; 13: 306—309.
4.
Pichichero ME , Treanor J.Economic impact of pertussis. Arch Pediatr Adolesc Med1997; 151: 35—40.
5.
Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BHPrevalence and incidence of adult pertussis in an urban population. JAMA1996; 275: 1672—1674.
6.
Watanabe M., Nagai M.Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther2004; 2: 447—454.
7.
Porter JF, Connor K., Donachie W.Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. Microbiology1994; 140: 255—261.
8.
Porter JF, Connor K., Donachie W.Differentiation between human and ovine isolates of Bordetella parapertussis using pulsed-field gel-electrophoresis. FEMS Microbiol Lett1996; 135: 131—135.
9.
Porter JF, Connor K., van der Zee A. et al. Characterization of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (lipopolysaccharide) epitopes, filamentous hemagglutinin production, cellular fatty-acid composition and antibiotic-sensitivity . FEMS Microbiol Lett1995; 132: 195—201.
10.
van derZee A., Mooi F., van Embden J., Musser J.Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences . J Bacteriol1997; 179: 6609—6617.
11.
Keil DJ, Fenwick B.Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs . J Am Vet Med Assoc1998; 212: 200—207.
12.
Speakman AJ , Dawson S., Binns SH, Gaskell CJ, Hart CA, Gaskell RMBordetella bronchiseptica infection in the cat. J Small Anim Pract1999; 40: 252—256.
13.
Rutter JMQuantitative observations on Bordetella bronchiseptica infection in atrophic rhinitis of pigs. Vet Rec1981; 108: 451—454.
14.
Goodnow RABiology of Bordetella bronchiseptica. Microbiol Rev1980; 44: 722—738.
15.
Cotter PA, Miller JFBordetella. In: Groisman E. (ed) Principles of bacterial pathogenesis. San Diego, CA: Academic Press, 2001; 619—674.
16.
Mallory FB, Horner AAPertussis: the histological lesion in the respiratory tract. J Med Res1912; XXVII: 115—123.
17.
Lapin JHWhooping cough. Springfield, IL: Charles C. Thomas, 1943.
18.
Mattoo S., Cherry JDMolecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev2005; 18: 326—382.
19.
Parkhill J. , Sebaihia M., Preston A. et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet2003; 35: 32—40.
20.
Preston A., Parkhill J., Maskell DJThe bordetellae: lessons from genomics. Nat Rev Microbiol2004; 2: 379—390.
21.
Cummings CA , Brinig MM, Lepp PW, van de Pas S., Relman DABordetella species are distinguished by patterns of substantial gene loss and host adaptation. J Bacteriol2004; 186: 1484—1492.
22.
Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FRBordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog2005; 1: e45.
23.
Bjornstad ON , Harvill ETEvolution and emergence of Bordetella in humans . Trends Microbiol2005; 13: 355—359.
24.
Grenfell BTDynamics and epidemiological impact of microparasites. In: Smith GL. (ed) New challenges to health: The threat of virus infection. Cambridge: Cambridge University Press, 2001; 33—52.
25.
Cone Jr TCWhooping cough is first described as a disease sui generis by Baillou in 1640 . Pediatrics1970; 46: 522.
Carbonetti NH, Artamonova GV, Van Rooijen N, Ayala VIPertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect Immun2007; 75: 1713—1720.
28.
Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ETPertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest2005; 115: 3594—3601.
29.
Mann PB, Kennett MJ, Harvill ETToll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis2004; 189: 833—836.
30.
Mann PB, Elder KD, Kennett MJ, Harvill ETToll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica . Infect Immun2004; 72: 6650—6658.
31.
Higgins SC, Lavelle EC, McCann C. et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol2003; 171: 3119—3127.
32.
Mann PB, Wolfe D., Latz E., Golenbock D., Preston A., Harvill ETComparative Toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun2005; 73: 8144—8152.
33.
Caroff M., Aussel L., Zarrouk H. et al. Structural variability and originality of the Bordetella endotoxins . J Endotoxin Res2001; 7: 63—68.
34.
Zarrouk H., Karibian D., Bodie S., Perry MB, Richards JC, Caroff M.Structural characterization of the lipids A of three Bordetella bronchiseptica strains: variability of fatty acid substitution. J Bacteriol1997; 179: 3756—3760.
35.
Caroff M., Deprun C., Richards JC, Karibian D.Structural characterization of the lipid A of Bordetella pertussis 1414 endotoxin . J Bacteriol1994; 176: 5156—5159.
36.
Sweet CR, Preston A., Toland E. et al. Relaxed acyl chain specificity of Bordetella UDP-N-acetylglucosamine acyltransferases. J Biol Chem2002; 277: 18281—18290.
37.
Trent MS, Stead CM, Tran AX, Hankins JVDiversity of endotoxin and its impact on pathogenesis. J Endotoxin Res2006; 12: 205—223.
38.
Preston A., Maxim E., Toland E. et al. Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol2003; 48: 725—736.
39.
Pilione MR, Pishko EJ, Preston A., Maskell DJ, Harvill ETPagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun2004; 72: 2837—2842.
40.
Geurtsen J. , Steeghs L., Hove JT, van der Ley P., Tommassen J.Dissemination of lipid a deacylases (PagL) among Gram-negative bacteria: identification of active-site histidine and serine residues. J Biol Chem2005; 280: 8248—8259.
41.
Gibbons HS, Lin S., Cotter RJ, Raetz CROxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, a new Fe2+/alphaketoglutarate-dependent dioxygenase homologue. J Biol Chem2000; 275: 32940—32949.
42.
Geurtsen J. , Steeghs L., Hamstra HJ et al. Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis . Infect Immun2006; 74: 5574—5585.
